NASDAQ OMX Welcomes CellaVision to the Main Market
Stockholm, May 31, 2010 - NASDAQ OMX (NASDAQ:NDAQ) announced that CellaVision AB (CEVI), a small cap company within the Health Care sector, today starts trading of its shares on the main market of NASDAQ OMX Stockholm. CellaVision is the sixth company to list on NASDAQ OMX Nordic markets in 2010, and the twentieth company to move from First North to the main market.
CellaVision develops and markets products for the health care sector, enabling fast and firm blood cell analysis and quality assurance of morphology diagnosis. The product line includes systems for automatic blood cell differentials and software for differential proficiency testing and education. The products are sold to hospital laboratories and independent commercial laboratories. CellaVision is headquartered are in Lund, Sweden and is today represented in Europe, North America and Asia.
Jenny Rosberg, Senior Vice President at NASDAQ OMX said, "We are pleased to welcome CellaVision to the main market where they will make a valuable contribution to our Health Care sector. CellaVision's listing today proves a great example of how a listing in our First North Premier segment can provide the necessary experience and capital strength before entering our main market."
Yvonne Mårtensson, CEO at CellaVision commented, "This is a very exciting day in the history of CellaVision, and we look forward to capitalizing on the increased investor exposure and brand awareness that comes with a main market listing."
About NASDAQ OMX
The NASDAQ OMX Group, Inc. is the world's largest exchange company. It delivers trading, exchange technology and public company services across six continents, with more than 3,600 listed companies. NASDAQ OMX offers multiple capital raising solutions to companies around the globe, including its U.S. listings market, NASDAQ OMX Nordic, NASDAQ OMX Baltic, NASDAQ OMX First North, and the U.S. 144A sector. The company offers trading across multiple asset classes including equities, derivatives, debt, commodities, structured products and exchange-traded funds. NASDAQ OMX technology supports the operations of over 70 exchanges, clearing organizations and central securities depositories in more than 50 countries. NASDAQ OMX Nordic and NASDAQ OMX Baltic are not legal entities but describe the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm, Iceland, Tallinn, Riga, and Vilnius. For more information about NASDAQ OMX, visit http://www.nasdaqomx.com. Please follow NASDAQ OMX on Facebook (http://www.facebook.com/nasdaqomx) and Twitter (http://www.twitter.com/nasdaqomx).
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about NASDAQ OMX's products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
CONTACTS:
The NASDAQ OMX Group, Inc.
Carl Norell
+46 8 405 66 39
carl.norell@nasdaqomx.com